Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
Gregory Cairncross(McGill University), Walter J. Curran(Piedmont Cancer Institute), Jan C. Buckner(McGill University), Minesh P. Mehta(Columbia University), Brian Berkey(RTOG Foundation), Normand Laperierre(University of Wisconsin–Madison), Robert B. Jenkins(Dartmouth–Hitchcock Medical Center), Edward Shaw(Wake Forest University), David Brachman(Barrow Neurological Institute), Karen Fink(McGill University), Bernd W. Scheithauer(Mayo Clinic), Luís Souhami(McGill University Health Centre)
Cited by 725
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k